|
Coronary Artery Calcium Score
|
6
|
Resverlogix Corp.
|
Dec 21, 2018 10:34AM
|
|
Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
5
|
Resverlogix Corp.
|
Jul 02, 2019 11:59AM
|
|
COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
6
|
Resverlogix Corp.
|
Dec 14, 2021 11:50AM
|
|
Crossing the blood-brain barrier: Bioasis Technologies lead the way with their xB3 technology platform
|
3
|
BIOASIS TECHNOLOGIES INC
|
Aug 22, 2018 02:19PM
|
|
CTAD Asia Alzheimer's Conference Sept 1 & 2
|
11
|
Resverlogix Corp.
|
Sep 01, 2018 09:25AM
|
|
CTAD Symposia Summary
|
4
|
Resverlogix Corp.
|
Dec 08, 2019 03:55PM
|
|
CTAD Twitter Exchange
|
4
|
Resverlogix Corp.
|
Nov 02, 2019 11:57AM
|
|
CVOTs on the Horizon
|
3
|
Resverlogix Corp.
|
Oct 01, 2018 04:04PM
|
|
Cytokine storm hypothesis takes a hit with the latest IL-6 targeted therapies
|
5
|
Resverlogix Corp.
|
Apr 27, 2020 12:42PM
|
|
Danny Levine, The Bio Report Interview with Mark Day, Ph.D., President & CEO, Bioasis
|
5
|
BIOASIS TECHNOLOGIES INC
|
Jul 12, 2018 03:15PM
|
|
Data highlights
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 05:07PM
|
|
DDF Summit: Drug Delivery & Formulation, August 28-29, 2017
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jul 28, 2017 01:54PM
|
|
December Corporate Presentation
|
4
|
BIOASIS TECHNOLOGIES INC
|
Dec 13, 2018 10:10AM
|
|
DECLARE TIMI-58 w/ prior MI as BETonMACE proxy?
|
3
|
Resverlogix Corp.
|
Mar 28, 2019 10:42AM
|
|
Delivery peptide conjugates of paclitaxel
|
|
BIOASIS TECHNOLOGIES INC
|
Oct 13, 2017 11:41AM
|
|
Delivery peptide conjugates of Trastuzumab
|
|
BIOASIS TECHNOLOGIES INC
|
Oct 13, 2017 11:34AM
|
|
Denali Interim Phase I/II Data for Hunter Syndrome (MPSII) Clinical Program
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 26, 2021 08:03AM
|
|
Denali news
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 28, 2019 10:07AM
|
|
Denali Therapeutics unveils BBB delivery system
|
2
|
BIOASIS TECHNOLOGIES INC
|
May 27, 2020 09:33PM
|
|
Denali/ATV and the advantages of BiOasis/xB3
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 19, 2018 11:55AM
|
